Loading...
Zepp Health Corporation
ZEPP•NYSE
Technology
Consumer Electronics
$13.73
$2.60(23.36%)
Zepp Health Corporation (ZEPP) Financial Performance & Income Statement Overview
Review Zepp Health Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-92.68%
↓ 92.68%
Operating Income Growth
77.19%
↑ 77.19%
Net Income Growth
64.30%
↑ 64.30%
Operating Cash Flow Growth
-157.26%
↓ 157.26%
Operating Margin
-11.41%
↓ 11.41%
Gross Margin
39.56%
↑ 39.56%
Net Profit Margin
-18.52%
↓ 18.52%
ROE
-28.84%
↓ 28.84%
ROIC
-16.22%
↓ 16.22%
Zepp Health Corporation (ZEPP) Income Statement & Financial Overview
Review Zepp Health Corporation's (ZEPP) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $59.54M | $42.46M | $295.33M | $287.23M |
| Cost of Revenue | $37.61M | $25.22M | $176.44M | $181.56M |
| Gross Profit | $21.93M | $17.24M | $118.89M | $105.67M |
| Gross Profit Ratio | $0.37 | $0.41 | $0.40 | $0.37 |
| R&D Expenses | $11.06M | $10.86M | $78.61M | $96.14M |
| SG&A Expenses | $19.81M | $18.92M | $111.97M | $123.27M |
| Operating Expenses | $30.87M | $29.78M | $190.58M | $219.41M |
| Total Costs & Expenses | $68.48M | $55.00M | $367.02M | $400.97M |
| Interest Income | $771000.00 | $941000.00 | $6.89M | $7.28M |
| Interest Expense | $1.45M | $1.29M | $9.98M | $10.37M |
| Depreciation & Amortization | $0.00 | $1.03M | $7.81M | $13.61M |
| EBITDA | -$19.03M | -$11.51M | -$63.87M | -$105.97M |
| EBITDA Ratio | -$0.32 | -$0.27 | -$0.22 | -$0.37 |
| Operating Income | -$8.94M | -$12.54M | -$71.69M | -$113.74M |
| Operating Income Ratio | -$0.15 | -$0.30 | -$0.24 | -$0.40 |
| Other Income/Expenses (Net) | -$11.54M | -$257000.00 | -$4.35M | $12.51M |
| Income Before Tax | -$20.48M | -$12.79M | -$76.03M | -$101.22M |
| Income Before Tax Ratio | -$0.34 | -$0.30 | -$0.26 | -$0.35 |
| Income Tax Expense | $13.57M | $465000.00 | $2.48M | $514000.00 |
| Net Income | -$36.88M | -$13.25M | -$78.75M | -$105.52M |
| Net Income Ratio | -$0.62 | -$0.31 | -$0.27 | -$0.37 |
| EPS | -$9.12 | -$0.82 | -$4.96 | -$6.52 |
| Diluted EPS | -$9.12 | -$0.82 | -$4.96 | -$6.52 |
| Weighted Avg Shares Outstanding | $4.04M | $16.15M | $16.27M | $16.22M |
| Weighted Avg Shares Outstanding (Diluted) | $4.04M | $16.15M | $16.27M | $16.22M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan